Data / Form D filings / LIPELLA PHARMACEUTICALS INC.
LIPELLA PHARMACEUTICALS INC.: Form D filings
LIPELLA PHARMACEUTICALS INC., a pharmaceuticals company in Pittsburgh, PA, filed 11 Form D notices with the SEC between 2009 and 2025. The latest, on April 1, 2025, reports $9,000 sold of a $9,000 offering to 29 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7800 SUSQUEHANNA ST., SUITE 505, Pittsburgh, PA, 15208
- Phone
- (412) 894-1853
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1347242
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | New notice | $9,000 | $9,000 | 29 | Mar 17, 2025 | sec.gov | |
| Jan 7, 2025 | New notice | $6,000,000 | $2,597,500 | $3,402,500 | 26 | Dec 23, 2024 | sec.gov |
| Aug 15, 2024 | New notice | $120,086 | $120,086 | 1 | Jul 31, 2024 | sec.gov | |
| Nov 7, 2023 | New notice | $2,000,000 | $2,000,000 | 1 | Oct 23, 2023 | sec.gov | |
| Sep 12, 2023 | New notice | $122,400 | $0 | $122,400 | 1 | Jul 10, 2023 | sec.gov |
| May 17, 2021 | Amendment | $3,600,000 | $3,121,602 | $478,398 | 43 | Oct 23, 2020 | sec.gov |
| Apr 12, 2021 | Amendment | $3,000,000 | $2,608,101 | $391,899 | 37 | Oct 23, 2020 | sec.gov |
| Nov 4, 2020 | New notice | $3,000,000 | $405,000 | $2,595,000 | 7 | Oct 23, 2020 | sec.gov |
| Jan 27, 2011 | Amendment | $1,000,000 | $251,424 | $748,576 | 6 | Sep 16, 2008 | sec.gov |
| Jan 29, 2010 | Amendment | $1,000,000 | $216,424 | $783,576 | 6 | Sep 16, 2008 | sec.gov |
| Sep 29, 2009 | Amendment | $1,000,000 | $146,424 | $853,576 | 5 | Sep 16, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lori Birder | Director | |
| Michael Chancellor | Executive Officer, Director | |
| Ryan Pruchnic | Director | |
| Jonathan Kaufman | Executive Officer, Director | |
| Daniel Cohen | Director | |
| Byong Kim | Director | |
| Douglas Johnston | Executive Officer | |
| Naoki Yoshimura | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Mar 31, 2025 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LIPELLA PHARMACEUTICALS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.